Working group of intellectual property

Contact

Português

English

GTPI supports judicial decision annulling patent HIV / AIDS medicine

(14.03.2011) GTPI welcomes the decision of the Judge since it converges with several actions taken by the group in recent years to put an end to undue monopolies

Setback in Brazil: Judge voids conviction against big pharma

(GTPI, 19.01.2012)

With an eye on new markets, Swiss Novartis decides to invest in Brazil

(Valor Econômico,09.01.2012) In the search for new markets to expand its business outside the United States-Europe axis, the Swiss drugmaker Novartis has decided to increase its investments in Brazil

INPI determines priority examination for HIV / AIDS medicines

(GTPI, 15.12.2011)Resolution No. 191/08 of the INPI, which rules the priority examination, does not set any specific deadline for the exam, but states that a commission must be set up to address the examination of the patent application.

Previous Posts

ur goal is to provide information and contribute to the debate on the impacts of patents on access to medicines and health care supplies and other essentials.

Know our group

A few people know what a patent is and what it's influence on access to medicines

Flickr

Youtube

Anterior

Próxima

Fonte: http://www.saudeemrede.org.br

ABIA

REPRIB

Ford Foundation

Alguns direitos reservados